EC4125 — House Communication 116th Congress (2019-2020)
Congressional Record Date: 03/11/2020
Federal Rulemaking: R8070
Abstract: A letter from the Assistant Administrator, Diversion Control Division, Drug Enforcement Administrator, Department of Justice, transmitting the Department's interim final rule - Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V [Docket No.: DEA-558] received March 6, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868); to the Committee on Energy and Commerce.
Referred to Committee Date:
- 03/11/2020 — House Energy and Commerce
Requirement Number: R8070
Agency: Multiple Executive Agencies and Departments
NATURE: Congressional review of agency rulemaking.
Legal Authority: 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868)